Cargando…

Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis

BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related death worldwide. Despite recent advances in imaging techniques and therapeutic intervention for HCC, the low overall 5-year survival rate of HCC patients remains unsatisfactory. This study aims to find a g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Guo-jie, Chen, Liang, Wu, Jin-cai, Li, Zhou-ri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2019
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431139/ https://www.ncbi.nlm.nih.gov/pubmed/30918751 http://dx.doi.org/10.7717/peerj.6548

Ejemplares similares

Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Zhang, Jin-Xing, et al.
Publicado: (2022)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma
por: Tang, Liping, et al.
Publicado: (2021)

Comprehensive analysis of metastasis-related genes reveals a gene signature predicting the survival of colon cancer patients
por: Wei, Haotang, et al.
Publicado: (2018)

Risk factors for malignant transformation of hepatocellular adenoma to hepatocellular carcinoma: protocol for systematic review and meta-analysis
por: Thevathasan, Tharusan, et al.
Publicado: (2021)

A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study
por: Zhou, Zheyu, et al.
Publicado: (2023)

Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis
por: Miao, Yan, et al.
Publicado: (2018)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib
por: Chen, Yen-Yang, et al.
Publicado: (2020)

Trials in developing a nanoscale material for extravascular contrast-enhanced ultrasound targeting hepatocellular carcinoma
por: Wu, Size, et al.
Publicado: (2020)

Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study
por: Huang, Chung-Feng, et al.
Publicado: (2019)

Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis
por: Thiele, Maja, et al.
Publicado: (2013)

Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis
por: Lu, Si-Cong, et al.
Publicado: (2015)

Coordinative control of G2/M phase of the cell cycle by non-coding RNAs in hepatocellular carcinoma
por: Shi, Jun, et al.
Publicado: (2018)

A new model predicts hepatocellular carcinoma in patients with HBV-related decompensated liver cirrhosis and long-term antiviral therapy: a prospective study
por: Mao, Hao-dan, et al.
Publicado: (2023)

The predictive role of preoperative serum glutamate dehydrogenase levels in microvascular invasion and hepatocellular carcinoma prognosis following liver transplantation—a single center retrospective study
por: Gong, Jinlong, et al.
Publicado: (2021)

Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study
por: Xie, Chengke, et al.
Publicado: (2022)

Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials
por: Kimer, Nina, et al.
Publicado: (2012)

Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
por: Kennedy, Oliver John, et al.
Publicado: (2017)

Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation
por: Zhang, Dali, et al.
Publicado: (2022)

A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma
por: Pang, Bing-yao, et al.
Publicado: (2022)

Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma
por: Zhang, Bo, et al.
Publicado: (2022)

Forecasting and predicting intussusception in children younger than 48 months in Suzhou using a seasonal autoregressive integrated moving average model
por: Guo, Wan-liang, et al.
Publicado: (2019)

Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study
por: Driver, Robert J, et al.
Publicado: (2019)

Utilization of hepatitis B surface antigen-positive donors in liver transplantation for recipients with hepatocellular carcinoma: a retrospective and propensity score matching analysis
por: Chen, Zhitao, et al.
Publicado: (2023)

Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation
por: Cao, Wei, et al.
Publicado: (2019)

Impact of multiple liver resections prior to salvage liver transplantation on survival in patients with recurrent HCC
por: Hu, Zhenhua, et al.
Publicado: (2015)

A contrast-enhanced CT-based whole-spleen radiomics signature for early prediction of oxaliplatin-related thrombocytopenia in patients with gastrointestinal malignancies: a retrospective study
por: Dai, Yuhong, et al.
Publicado: (2023)

Prediction models for the survival in patients with intestinal-type gastric adenocarcinoma: a retrospective cohort study based on the SEER database
por: Hong, Jiawen, et al.
Publicado: (2023)

Efficacy and safety of lenvatinib–transcatheter arterial chemoembolisation sequential therapy followed by surgical resection for intermediate-stage hepatocellular carcinoma beyond Up-to-7 criteria: a study protocol for a multicentre, single-arm, prospective study
por: Oshita, Ko, et al.
Publicado: (2023)

KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study
por: Oudmaijer, Christiaan Albert Johan, et al.
Publicado: (2022)

Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma
por: Luo, Yun, et al.
Publicado: (2022)

Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China
por: Zhang, Xiangyan, et al.
Publicado: (2018)

Education level and survival after oesophageal cancer surgery: a prospective population-based cohort study
por: Brusselaers, Nele, et al.
Publicado: (2013)

Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis
por: Yu, Xue-Chen, et al.
Publicado: (2022)

Influence of surgical margin width on survival rate after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
por: Jiang, Jing-Hua, et al.
Publicado: (2023)

A machine learning approach for identification of gastrointestinal predictors for the risk of COVID-19 related hospitalization
por: Lipták, Peter, et al.
Publicado: (2022)

Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial
por: Vilar Gomez, Eduardo, et al.
Publicado: (2011)

Upper Gastrointestinal Hemorrhage as an Unexpected Feature of Hepatocellular Carcinoma
por: Coelho, Rosa, et al.
Publicado: (2015)

Inflammation-based prognostic scores predict the prognosis of locally advanced cervical esophageal squamous cell carcinoma patients receiving curative concurrent chemoradiotherapy: a propensity score-matched analysis
por: Wu, Chia-Che, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_f19vc9leq6gor4vsb52qc62on0